Jonathan Knowles

Biography

 Jonathan Knowles, PhD, joined the Caris Life Sciences™ (Caris) Board of Directors on September 1, 2009 and accepted the position of vice chairman starting on January 1, 2010. Dr. Knowles’ distinguished career has spanned decades in both academia and the pharmaceutical industry, including his most recent role as president of group research at Roche, a position he has held since 2007, and member of that organization’s Corporate Executive Committee, which he has held since 1998. Dr. Knowles was also a member of the Genentech Board for the last 12 years and a member of the Chugai Board for seven years. Additionally, Dr. Knowles was the chairman of the Corporate Governance Committee of Genentech. He was for five years the chairman of the Research Directors’ Group of EFPIA (European Federation of Pharmaceutical Industry Associations) and was the first chairman of the Board of the Innovative Medicines Initiative, a unique public-private partnership between 28 Pharmaceutical companies and the European Commission with a budget of more than 2 Billion Euros over five years. Dr. Knowles focused the company on key disease biology areas of high medical need and in-depth understanding of molecular pathology of disease. Under his leadership, the company developed and implemented a strategy of highly effective therapies based on personalized healthcare and built one of the best pharmaceutical pipelines in the sector.

Research Interest

 Pharmaceutics